.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
QuintilesIMS
McKinsey
US Department of Justice
Teva
Healthtrust
Queensland Health
Chubb
UBS
Johnson and Johnson

Generated: November 18, 2017

DrugPatentWatch Database Preview

JUBLIA Drug Profile

« Back to Dashboard

Which patents cover Jublia, and what generic Jublia alternatives are available?

Jublia is a drug marketed by Dow Pharm and is included in one NDA. There are six patents protecting this drug.

This drug has forty-four patent family members in twenty-one countries.

The generic ingredient in JUBLIA is efinaconazole. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the efinaconazole profile page.

Pharmacology for JUBLIA

Ingredient-typeAzoles
Drug ClassAzole Antifungal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dow Pharm
JUBLIA
efinaconazole
SOLUTION;TOPICAL203567-001Jun 6, 2014RXYesYes► Subscribe► Subscribe ► Subscribe
Dow Pharm
JUBLIA
efinaconazole
SOLUTION;TOPICAL203567-001Jun 6, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Dow Pharm
JUBLIA
efinaconazole
SOLUTION;TOPICAL203567-001Jun 6, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Dow Pharm
JUBLIA
efinaconazole
SOLUTION;TOPICAL203567-001Jun 6, 2014RXYesYes► Subscribe► Subscribe ► Subscribe
Dow Pharm
JUBLIA
efinaconazole
SOLUTION;TOPICAL203567-001Jun 6, 2014RXYesYes► Subscribe► Subscribe ► Subscribe
Dow Pharm
JUBLIA
efinaconazole
SOLUTION;TOPICAL203567-001Jun 6, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Dow Pharm
JUBLIA
efinaconazole
SOLUTION;TOPICAL203567-001Jun 6, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: JUBLIA

Country Document Number Estimated Expiration
Australia2008343795► Subscribe
BrazilPI0822162► Subscribe
Argentina070083► Subscribe
China101909634► Subscribe
Australia5852400► Subscribe
Germany60042453► Subscribe
Russian Federation2519664► Subscribe
Canada2391274► Subscribe
Japan5623913► Subscribe
World Intellectual Property Organization (WIPO)2015051183► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Chinese Patent Office
Mallinckrodt
Novartis
Cerilliant
QuintilesIMS
AstraZeneca
Dow
Fish and Richardson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot